Goldan Keith A.'s Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Feb 6, 2026
- Accession no.
- 0001193125-26-041497
- Filed
- Feb 6, 2026
- Trade date
- Jan 30-Feb 6, 2026
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $42.9K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldan Keith A.CIK 0001495411 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Common Stock | JOtherAcquired | +1,219 | $8.48 | +$10,337.12 | 93,671 | Direct | |
| Feb 4, 2026 | Common Stock | AGrant or awardAcquired | +21,500 | $0.00 | $0 | 115,171 | Direct | |
| Feb 4, 2026 | Common Stock | AGrant or awardAcquired | +30,750 | $0.00 | $0 | 145,921 | Direct | |
| Feb 6, 2026 | Common Stock | SSaleDisposed | −2,082 | $20.62 | −$42,930.84 | 143,839 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Common Stock | AGrant or awardAcquired | +118,000 | $20.43 | +$2,410,740 | 118,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.